• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

76
19
14
11
11

COUNTRY

11
3
2
2
1

PRICE

65
100
204
273

PUBLISHED

0
6
53
273

PRODUCT TYPE

254
16
2
1

Women's Health

(273 Products)

Women are increasingly attractive to pharmaceuticals company. From adolescence to old age they come into contact with the medical services far more than men, and this gives pharmaceutical companies the opportunity to target women as a distinct customer group characterized by brand loyalty. Business opportunities are also provided by the emerging countries, where women are increasingly empowered to access reproductive and other health services.

Browse Research and Markets’ Women’s Health category to identify investment, business development and partnership opportunities across a variety of issues such as contraception, pregnancy, female infertility, dysmenorrheal, menopausal disorders, ovarian disease, vaginal atrophy, and more. Monitor the latest drug trials, enhance your clinical knowledge and explore specific markets with our reports, books, and subscriptions.

Leading players featured in our publications include Wyeth, Schering, Johnson & Johnson, and more. Show Less
Read more

Women’s Health - Assessing the Need for a Targeted and Specialized Approach Women’s Health - Assessing the Need for a Targeted and Specialized Approach - Product Thumbnail Image

Women’s Health - Assessing the Need for a Targeted and Specialized Approach

Many of the diseases and conditions that affect mainly women are interlinked with similar root causes; however, placing all of the pieces of the puzzle together to ensure a cohesive management strategy...

January 2015
FROM

Global Female Condom Market 2014-2018

About Female Condoms A condom is a barrier method commonly used during sexual intercourse that reduces the chances of pregnancy and the spread of STDs and AIDS. Condoms are also widely recommended...

October 2014
FROM

North American Intrauterine Contraceptive Devices (IUCD) Market by Type (Female Contraceptive devices, Male Contraceptive devices) - Forecast to 2019

The North America intrauterine contraceptive devices market is estimated to grow at a CAGR of 0.3% from 2014 to 2019. The growth of the intrauterine contraceptive devices market is driven by factors...

February 2015
FROM

Global Women's Health Market 2014-2018

About Women’s Health Women experience physiological and emotional issues during different phases of their life cycle due to hormonal changes. Women's health is especially referred to where reproductive...

July 2014
FROM

Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19)

The report titled “Global Combined Hormonal Contraceptive (CHC) Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of the global CHC market with detailed analysis of market...

January 2015
FROM
Global and Chinese Progesterone Industry Report 2014 Global and Chinese Progesterone Industry Report 2014 - Product Thumbnail Image

Global and Chinese Progesterone Industry Report 2014

The Global and Chinese Progesterone Industry Report 2014 is a professional and in-depth study on the current state of the progesterone industry with a focus on the Chinese situation The report provides...

July 2014
FROM

Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] – Global Forecast to 2019

The global intrauterine contraceptive devices market is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The growth of the intrauterine contraceptive devices market is driven by factors such as...

April 2015
FROM

Mammography World Markets

Breast cancer is the most common type of cancer in women, affecting one in eight during their lives Mammography is the most valuable method for detecting potentially cancerous anomalies in the breast...

December 2012
FROM
Global Markets for Aesthetic Procedures In 2012 Global Markets for Aesthetic Procedures In 2012 - Product Thumbnail Image

Global Markets for Aesthetic Procedures In 2012

The global market for the aesthetic devices analyzed in this report was valued at nearly $4 3 billion in 2011 The market has fluctuated in recent years and saw declines in 2009 The year 2011, however,...

August 2012
FROM

Cervical Dysplasia - Pipeline Review, H1 2015

Cervical Dysplasia - Pipeline Review, H1 2015 Summary The‘Cervical Dysplasia - Pipeline Review, H1 2015’, provides an overview of the Cervical Dysplasia’s therapeutic pipeline. This report...

May 2015
FROM

Dysmenorrhea - Pipeline Review, H1 2015

Dysmenorrhea - Pipeline Review, H1 2015 Summary The‘Dysmenorrhea - Pipeline Review, H1 2015’, provides an overview of the Dysmenorrhea’s therapeutic pipeline. This report provides comprehensive...

May 2015
FROM

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2015

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2015 Summary The‘Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2015’, provides an overview of the Vaginal Atrophy (Atrophic...

May 2015
FROM

Unsafe Abortion and Women's Health

Unsafe abortion remains one of the most neglected sexual and reproductive health problems according to the World Health Organisation. In recent years it has been estimated that over 20 million abortions...

May 2015

Menopausal Hot Flashes - Pipeline Review, H1 2015

Menopausal Hot Flashes - Pipeline Review, H1 2015 Summary This, ‘Menopausal Hot Flashes - Pipeline Review, H1 2015’, provides an overview of the Menopausal Hot Flashes’s therapeutic pipeline. This...

April 2015
FROM

Technology Trends in Women's Health (Technical Insights)

In almost all parts of the world, women live longer than men. The exact cause behind the differential between male and female life expectancy is uncertain, but it appears to be partly explained by biological...

March 2015
FROM

Premenstrual Syndrome - Pipeline Review, H1 2015

Premenstrual Syndrome - Pipeline Review, H1 2015 Summary This, ‘Premenstrual Syndrome - Pipeline Review, H1 2015’, provides an overview of the Premenstrual Syndrome’s therapeutic pipeline. This report...

January 2015
FROM

Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015

Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015 Summary This, ‘Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015’, provides an overview of the Female Hypoactive...

January 2015
FROM

Endometriosis - Pipeline Review, H1 2015

Endometriosis - Pipeline Review, H1 2015 Summary This, ‘Endometriosis - Pipeline Review, H1 2015’, provides an overview of the Endometriosis’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Polycystic Ovarian Syndrome - Pipeline Review, H1 2015

Polycystic Ovarian Syndrome - Pipeline Review, H1 2015 Summary This, ‘Polycystic Ovarian Syndrome - Pipeline Review, H1 2015’, provides an overview of the Polycystic Ovarian Syndrome’s therapeutic...

January 2015
FROM
Loestrin 24 Fe-Drug Insights,2014 Loestrin 24 Fe-Drug Insights,2014 - Product Thumbnail Image

Loestrin 24 Fe-Drug Insights,2014

“Loestrin 24 Fe - Drug Insights, 2014” provides Loestrin 24 Fe marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the...

February 2015
FROM
Loading Indicator

Our Clients

Actavis Smith & Nephew PLC. Bayer AG Hologic Corporation Abbott Laboratories Ltd. Polpharma SA